Journal article
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer
Abstract
BACKGROUND: Compared to patients without cancer, patients with cancer receiving anticoagulant treatment for venous thromboembolism are more likely to develop recurrent venous thromboembolism (VTE).
OBJECTIVES: To compare the efficacy and safety of three types of anticoagulants (i.e. low molecular weight heparin (LMWH), unfractionated heparin (UFH), and fondaparinux) for the initial treatment of VTE in patients with cancer.
Authors
Akl EA; Rohilla S; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H
Journal
, , No. 1,
Publisher
Wiley
DOI
10.1002/14651858.cd006649.pub2
ISSN
1465-1858